InspireMD (NSPR) Cash from Investing Activities (2010 - 2025)
InspireMD (NSPR) reported Cash from Investing Activities of -$45.1 million for Q4 2025, down 647.62% on a YoY basis from $8.2 million in Q4 2024, and down 697.74% quarter-over-quarter from $7.6 million in Q3 2025.
InspireMD (NSPR) Cash from Investing Activities (2010 - 2025) Analysis & Trends
InspireMD has reported Cash from Investing Activities for 16 years, with the latest figure at -$45.1 million in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities fell 647.62% year-over-year to -$45.1 million; the trailing twelve-month figure through Dec 2025 stood at -$30.6 million (down 341.75% YoY), and the FY2025 full-year result was -$30.6 million, down 341.75% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$45.1 million, down from $7.6 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $8.2 million in Q4 2024, with the low at -$45.1 million in Q4 2025.
- Historically, Cash from Investing Activities has averaged -$2.4 million across 5 years, with a median of $1.9 million in 2021.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities slumped 49255.1% — and 2024, when it soared 22994.44%.
- InspireMD's Cash from Investing Activities stood at $1.8 million in 2021, then soared by 111.08% to $3.9 million in 2022, then tumbled by 100.93% to -$36000.0 in 2023, then soared by 22994.44% to $8.2 million in 2024, then sank by 647.62% to -$45.1 million in 2025.
- The last three Cash from Investing Activities figures came in at -$45.1 million (Q4 2025), $7.6 million (Q3 2025), and $5.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | InspireMD | 48.12 Mn | -6.10 Mn | 1.18 Mn | -45.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45.14 Mn |
| Dec 31, 2025 | -45.14 Mn |
| Sep 30, 2025 | 7.55 Mn |
| Sep 30, 2025 | 7.55 Mn |
| Jun 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | 5.32 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | 8.24 Mn |
| Dec 31, 2024 | 8.24 Mn |
| Sep 30, 2024 | -5.92 Mn |
| Sep 30, 2024 | -5.92 Mn |
| Jun 30, 2024 | 5.51 Mn |
| Jun 30, 2024 | 5.51 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Dec 31, 2023 | -36,000.00 |
| Dec 31, 2023 | -36,000.00 |
| Sep 30, 2023 | 6.39 Mn |
| Sep 30, 2023 | 6.39 Mn |